- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 2.35 | - |
NAV | ₹17.18 | - |
Fund Started | 18 Oct 2021 | - |
Fund Size | ₹230.79 Cr | - |
Exit Load | Exit load of 1% if redeemed within 12 months. | - |
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹500
-
Expense Ratio
2.35
-
NAV
₹17.18
-
Fund Started
18 Oct 2021
-
Fund Size
₹230.79 Cr
-
Exit Load
Exit load of 1% if redeemed within 12 months.
-
Returns
1 Year | 35.09% | - |
3 Year | 19.32% | - |
5 Year | - | - |
1 Year
35.09%
-
3 Year
19.32%
-
5 Year
-
-
Holding Analysis
Equity | 95.26% | - |
Cash | 4.74% | - |
Equity
95.26%
-
Cash
4.74%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 15.23% |
Lupin Ltd. | 6.02% |
Suven Pharmaceuticals Ltd. | 5.76% |
Aurobindo Pharma Ltd. | 4.85% |
Divi's Laboratories Ltd. | 4.77% |
Apollo Hospitals Enterprise Ltd. | 4.75% |
Torrent Pharmaceuticals Ltd. | 3.70% |
Max Healthcare Institute Ltd. | 3.53% |
Laurus Labs Ltd. | 3.20% |
Syngene International Ltd. | 2.71% |
-
Fund Manager
Name | Dhimant Shah | - |
Start Date | 01 Dec 2022 | - |
Name
Dhimant Shah
-
Start Date
01 Dec 2022
-
About Fund
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. | - |
Launch Date | 18 Oct 2021 | - |
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
-
Launch Date
18 Oct 2021
-
